Title:
化合物
Document Type and Number:
Japanese Patent JP2008525394
Kind Code:
A
Abstract:
The use of a compound of the formula (I), or a pharmaceutically acceptable salt or an in vivo hydrolysable ester thereof in the manufacture of a medicament for the treatment of Mycobacterium tuberculosis (M.tb).
More Like This:
| WO2000002857 | BIS-INDOLE DERIVATIVES AND THEIR USE AS ANTIINFLAMMATORY AGENTS |
| WO/2005/002525 | COX-2 AND FAAH INHIBITORS |
| JP2001512439 | INDUSTRIAL APPLICABILITY PRODrug of a fibrinoceptor antagonist |
Inventors:
Flicker, Vijay Kumar
Lao, Langa Lao Kazipalya Langanasa
Lao, Langa Lao Kazipalya Langanasa
Application Number:
JP2007547617A
Publication Date:
July 17, 2008
Filing Date:
December 16, 2005
Export Citation:
Assignee:
AstraZeneca Activrag
International Classes:
C07D209/42; A61K31/404; A61K31/41; A61K31/433; A61P31/06; C07D403/04; C07D405/06; C07D405/12; C07D409/06; C07D409/12; C07D417/12
Domestic Patent References:
| JPH02165131A | 1990-06-26 | |||
| JP2003502279A | 2003-01-21 | |||
| JP2001513494A | 2001-09-04 | |||
| JP2001527066A | 2001-12-25 |
Attorney, Agent or Firm:
Kazuo Shamoto
Shinjiro Ono
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Mitsutoshi Nakamura
Shinjiro Ono
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Mitsutoshi Nakamura